Implementation and Clinical Utility of an Integrated Academic-Community Regional Molecular Tumor Board | Zendy

Mark E. Burkard | Zendy; Dustin A. Deming | Zendy; Benjamin M. Parsons | Zendy; Paraic A. Kenny | Zendy; Marissa Schuh | Zendy; Ticiana Leal | Zendy; Nataliya V. Uboha | Zendy; Joshua M. Lang | Zendy; Michael A. Thompson | Zendy; Ruth Warren | Zendy; Jordan Bauman | Zendy; Mary Mably | Zendy; Jennifer Laffin | Zendy; Catherine R. Paschal | Zendy; Angela M. Lager | Zendy; Kristy Lee | Zendy; Kristina A. Matkowskyj | Zendy; Darya Buehler | Zendy; William M. Rehrauer | Zendy; Jill Kolesar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Implementation and Clinical Utility of an Integrated Academic-Community Regional Molecular Tumor Board

Author(s) -

Mark E. Burkard,

Dustin A. Deming,

Benjamin M. Parsons,

Paraic A. Kenny,

Marissa Schuh,

Ticiana Leal,

Nataliya V. Uboha,

Joshua M. Lang,

Michael A. Thompson,

Ruth Warren,

Jordan Bauman,

Mary Mably,

Jennifer Laffin,

Catherine R. Paschal,

Angela M. Lager,

Kristy Lee,

Kristina A. Matkowskyj,

Darya Buehler,

William M. Rehrauer,

Jill Kolesar

Publication year - 2017

Publication title -

jco precision oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.405

H-Index - 22

ISSN - 2473-4284

DOI - 10.1200/po.16.00022

Subject(s) - medicine , medical education

Precision oncology develops and implements evidence-based personalized therapies that are based on specific genetic targets within each tumor. However, a major challenge that remains is the provision of a standardized, up-to-date, and evidenced-based precision medicine initiative across a geographic region.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research